Siga Technologies (SIGA) EPS (Diluted) Growth (1y) (2011 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) EPS (Diluted) Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn | -0.91% |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn | 284.27% |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn | -130.72% |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn | -15.92% |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn | -108.14% |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn | 38.02% |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn | 13.47% |
| 10 | Siga Technologies | 217.68 Mn | 62.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -574.74% |
| Jun 30, 2025 | 1,873.17% |
| Mar 31, 2025 | -103.61% |
| Dec 31, 2024 | -36.87% |
| Sep 30, 2024 | 438.67% |
| Jun 30, 2024 | 161.95% |
| Mar 31, 2024 | 1,229.85% |
| Dec 31, 2023 | 9,232.60% |
| Sep 30, 2023 | -101.23% |
| Jun 30, 2023 | -249.24% |
| Mar 31, 2023 | -160.11% |
| Dec 31, 2022 | -101.15% |
| Sep 30, 2022 | 1,184.16% |
| Jun 30, 2022 | 902.42% |
| Mar 31, 2022 | 78.10% |
| Dec 31, 2021 | 278.44% |
| Sep 30, 2021 | -113.44% |
| Jun 30, 2021 | -101.30% |
| Mar 31, 2021 | 79.63% |
| Dec 31, 2020 | 532.78% |